Silliman Christopher C, Burke Timothy, Kelher Marguerite R
Bonfils Blood Center, Denver, CO, United States of America.
Department of Pediatrics, School of Medicine, University of Colorado Denver, Aurora, CO, United States of America.
Blood Transfus. 2017 Mar;15(2):131-136. doi: 10.2450/2017.0314-16.
Pre-storage leucoreduction has been universally adopted in most developed countries in Asia, Europe and the Americas. It decreases febrile transfusion reactions, alloimmunisation to HLA antigens, cytomegalovirus exposure, the accumulation of a number of pro-inflammatory mediators in the supernatant, including the accumulation of platelet-and leucocyte-derived proteins and metabolites during routine storage. This review will highlight the lipids and proteins, biological response modifiers (BRMs) that accumulate, their clinical effects in transfused hosts, and methods of mitigation.
在亚洲、欧洲和美洲的大多数发达国家,储存前白细胞滤除已被普遍采用。它可减少发热性输血反应、对HLA抗原的同种免疫、巨细胞病毒暴露,以及上清液中多种促炎介质的积累,包括常规储存期间血小板和白细胞衍生蛋白质及代谢产物的积累。本综述将重点介绍储存期间积累的脂质、蛋白质、生物反应调节剂(BRM)、它们在受血者中的临床效应以及缓解方法。